share_log

HC Wainwright & Co. Initiates Coverage On Reneo Pharmaceuticals With Buy Rating, Announces Price Target of $30

HC Wainwright & Co. Initiates Coverage On Reneo Pharmaceuticals With Buy Rating, Announces Price Target of $30

HC Wainwright & Co.以买入评级开始对瑞诺制药进行报道,宣布目标股价为30美元
Benzinga ·  2023/08/28 06:15

HC Wainwright & Co. analyst Gobind Singh initiates coverage on Reneo Pharmaceuticals (NASDAQ:RPHM) with a Buy rating and announces Price Target of $30.

HC Wainwright&Co.分析师戈宾德·辛格以买入评级开始报道Reneo制药公司(纳斯达克代码:RPHM),并宣布目标价为30美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发